Better off staying at Merck. Amgen is a short term gig. Too many layoffs there. Much more stabile at Merck
Most likely Sanofi and Pfizer will do better in this market. Also, Amgen's heart failure drug, Ivabradine, has bad press (which will spill over to their PCSK9 drug Evolocumab), while Novartis' heart failure drug (LCZ696) is receiving accolades. Amgen reps will not have it easy.
Novartis is worse than Amgen, and Pfizer is worse than Novartis. Merck is the place to be. Better culture and pay!
If you think that anyone interviewing would admit it on CP you're smoking crack. Merck is tracking this sh$t.
Ha, ccr rep here in my scrubs gettin free wifi at starbucks. I let my CV rep do all the work and sampling. They do the work and I share the credit, I am a true ccr star y'all.